Ligand Pharmaceuticals Incorporated (LGND) Competitors

$101.29

south_east
-$2.56 (-2.46%)
Day's range
$97.48
Day's range
$104.86

Ligand Pharmaceuticals Incorporated Competitors

Symbol Share Price Market Cap P/E Ratio Employee Count
AKRO

Akero Therapeutics, Inc.

$34.82 $2.76 B -9.26 63
ANNX

Annexon, Inc.

$1.38 $151.40 M -1.37 100
APLS

Apellis Pharmaceuticals, Inc.

$18.79 $2.36 B -11.76 705
ASND

Ascendis Pharma A/S

$143.33 $8.58 B -19.99 1017
BGNE

BeiGene, Ltd.

$208.31 $20.21 B -22.55 10600
BPMC

Blueprint Medicines Corporation

$80.27 $5.13 B -75.07 649
CGEM

Cullinan Oncology, Inc.

$7.58 $442.42 M -2.72 111
CRNX

Crinetics Pharmaceuticals, Inc.

$26.85 $2.50 B -7.28 437
CYTK

Cytokinetics, Incorporated

$37.85 $4.49 B -7.21 498
DSGN

Design Therapeutics, Inc.

$2.79 $156.38 M -3.13 54
ETNB

89bio, Inc.

$5.00 $724.08 M -1.41 93
GPCR

Structure Therapeutics Inc.

$15.05 $286.82 M -6.42 163
ICVX

Icosavax, Inc.

$15.31 $769.04 M -6.96 60
LYEL

Lyell Immunopharma, Inc.

$0.41 $123.11 M -0.32 300
ORIC

ORIC Pharmaceuticals, Inc.

$4.31 $305.06 M -2.35 115
PASG

Passage Bio, Inc.

$0.36 $22.86 M -0.34 60
RCUS

Arcus Biosciences, Inc.

$7.50 $791.69 M -2.38 627
RLAY

Relay Therapeutics, Inc.

$2.22 $378.03 M -0.94 261
TERN

Terns Pharmaceuticals, Inc.

$2.14 $186.38 M -1.91 59
VRDN

Viridian Therapeutics, Inc.

$11.41 $929.74 M -3.72 143